• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦的 PEP 登记处:1998 年至 2006 年期间,针对因性接触感染 HIV 而接受暴露后预防(PEP)的经验。

The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006.

机构信息

Department of Infectious Diseases, Helsingor Hospital, Helsingor, Denmark.

出版信息

Sex Transm Dis. 2010 Jan;37(1):49-52. doi: 10.1097/OLQ.0b013e3181b6f284.

DOI:10.1097/OLQ.0b013e3181b6f284
PMID:19734819
Abstract

BACKGROUND

Studies indicate that antiretroviral postexposure prophylaxis (PEP) after sexual exposure to HIV reduce the risk of infection considerably. Since 1998 PEP after sexual HIV exposure within the preceding 24 hours, has been available in Denmark. PEP can only be prescribed at clinical centers with specialists experienced in HIV treatment. The objective of this study is to describe the use of PEP after sexual exposure from 1998 to 2006.

METHODS

The Danish PEP registry collects data from all cases of PEP use in Denmark after exposure to HIV through a structured questionnaire.

RESULTS

There were 374 cases of PEP use after sexual exposure. The incidence increased from 5 cases in 1997 to 87 in 2006. PEP was used by heterosexuals (40%) as well as men who have sex with men (57%). The HIV-status of the source was unknown in 41% of the cases of which 90% involved a source belonging to a high risk group, and 63% involved exposure by receptive anal intercourse. PEP was administered within 24 hours in 95% of the cases and the median time to initiation (N = 225) was 11.0 hours (range 0.5-60.0). PEP was completed by 65%.

CONCLUSIONS

This nationwide study showed a steady but moderate increase in the use of PEP after sexual HIV-exposure from 1998 to 2006. Time to initiation of PEP was low and the PEP prescription practice was targeted toward high risk exposures.

摘要

背景

研究表明,在 HIV 性接触后使用抗逆转录病毒暴露后预防(PEP)可大大降低感染风险。自 1998 年以来,在丹麦,对于 24 小时内发生的 HIV 性接触暴露,已经可以提供 PEP。PEP 只能在具有 HIV 治疗经验的专家的临床中心开具。本研究的目的是描述 1998 年至 2006 年期间因性接触而使用 PEP 的情况。

方法

丹麦的 PEP 登记处通过结构化问卷从丹麦所有使用 PEP 的病例中收集数据。

结果

共有 374 例因性接触而使用 PEP。发病率从 1997 年的 5 例增加到 2006 年的 87 例。PEP 的使用者包括异性恋者(40%)和男男性接触者(57%)。在 41%的情况下,暴露源的 HIV 状态未知,其中 90%涉及属于高风险群体的来源,63%涉及接受性肛交暴露。在 95%的情况下,PEP 在 24 小时内给予,中位开始时间(N=225)为 11.0 小时(范围 0.5-60.0)。有 65%的人完成了 PEP。

结论

这项全国性研究表明,1998 年至 2006 年期间,因 HIV 性接触而使用 PEP 的情况稳步但适度增加。PEP 的起始时间较短,PEP 处方的目标是高危暴露。

相似文献

1
The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006.丹麦的 PEP 登记处:1998 年至 2006 年期间,针对因性接触感染 HIV 而接受暴露后预防(PEP)的经验。
Sex Transm Dis. 2010 Jan;37(1):49-52. doi: 10.1097/OLQ.0b013e3181b6f284.
2
Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004.2000 - 2004年阿姆斯特丹性接触后HIV暴露后预防用药的处方趋势及依从性
Sex Transm Dis. 2007 May;34(5):288-93. doi: 10.1097/01.olq.0000237838.43716.ee.
3
HIV post-exposure prophylaxis in children and adolescents presenting for reported sexual assault.针对报告遭受性侵犯的儿童和青少年的HIV暴露后预防。
Child Abuse Negl. 2009 Mar;33(3):173-8. doi: 10.1016/j.chiabu.2008.05.010. Epub 2009 Mar 25.
4
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.性接触或注射吸毒暴露后预防人类免疫缺陷病毒感染的暴露后预防(PEP)的可行性:旧金山PEP研究
J Infect Dis. 2001 Mar 1;183(5):707-14. doi: 10.1086/318829. Epub 2001 Feb 1.
5
Seroconversion following nonoccupational postexposure prophylaxis against HIV.非职业性暴露后预防HIV感染后的血清转化
Clin Infect Dis. 2005 Nov 15;41(10):1507-13. doi: 10.1086/497268. Epub 2005 Oct 13.
6
Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.性接触或注射吸毒后暴露于人类免疫缺陷病毒后的暴露后预防的成本效益
Arch Intern Med. 2004 Jan 12;164(1):46-54. doi: 10.1001/archinte.164.1.46.
7
HIV post-exposure prophylaxis provided at an urban paediatric emergency department to female adolescents after sexual assault.在城市儿科急诊科为遭受性侵犯后的女性青少年提供的艾滋病毒暴露后预防措施。
Emerg Med J. 2004 Jul;21(4):449-51.
8
The Danish PEP Registry: Experience with the use of post-exposure prophylaxis following blood exposure to HIV from 1999-2012.丹麦 PEP 登记处:1999-2012 年期间,针对因血液接触 HIV 而进行暴露后预防的使用经验。
Infect Dis (Lond). 2016;48(3):195-200. doi: 10.3109/23744235.2015.1103896. Epub 2015 Nov 3.
9
[Post-exposure HIV prevention within and outside the hospital].[医院内外的暴露后艾滋病毒预防]
Ther Umsch. 1998 May;55(5):289-94.
10
[Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure].暴露后艾滋病毒预防:近期因性接触感染患者的资格
Schweiz Med Wochenschr. 1999 Feb 27;129(8):314-8.

引用本文的文献

1
Single-dose infusion of engineered viral receptor binding domain confers rapid and durable protection against viral infection.单剂量输注工程化病毒受体结合域可提供针对病毒感染的快速且持久的保护。
Commun Biol. 2025 Aug 25;8(1):1279. doi: 10.1038/s42003-025-08704-6.
2
Adherence, adverse drug reactions, and discontinuation associated with adverse drug reactions of HIV post-exposure prophylaxis: a meta-analysis based on cohort studies.HIV 暴露后预防药物的依从性、不良反应及与不良反应相关的停药:基于队列研究的荟萃分析。
Ann Med. 2023;55(2):2288309. doi: 10.1080/07853890.2023.2288309. Epub 2023 Dec 8.
3
Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxis.
通过数据链接评估寻求暴露后预防个体的 HIV 感染长期风险。
Nat Commun. 2021 Feb 22;12(1):1219. doi: 10.1038/s41467-021-21485-w.
4
Expert consensus statement on the science of HIV in the context of criminal law.关于刑法中 HIV 科学的专家共识声明。
J Int AIDS Soc. 2018 Jul;21(7):e25161. doi: 10.1002/jia2.25161.
5
Suspected unexpected and other adverse reactions to antiretroviral drugs used as post-exposure prophylaxis of HIV infection - five-year experience from clinical practice.用于HIV感染暴露后预防的抗逆转录病毒药物的疑似意外及其他不良反应——临床实践五年经验
Arch Med Sci. 2018 Apr;14(3):547-553. doi: 10.5114/aoms.2016.59701. Epub 2016 May 5.
6
Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.暴露前和暴露后预防以及联合HIV预防方法(The Combine!研究):巴西公共医疗诊所一项实用临床试验的方案
BMJ Open. 2015 Aug 25;5(8):e009021. doi: 10.1136/bmjopen-2015-009021.
7
Non-occupational post-exposure prophylaxis for HIV: 10-year retrospective analysis in Seattle, Washington.非职业性HIV暴露后预防:华盛顿州西雅图市的10年回顾性分析
PLoS One. 2014 Aug 20;9(8):e105030. doi: 10.1371/journal.pone.0105030. eCollection 2014.
8
Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.预防HIV感染的非职业性暴露后预防实用指南:一篇编辑评论
AIDS. 2014 Jul 17;28(11):1545-54. doi: 10.1097/QAD.0000000000000301.
9
A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV.一项针对接受 HIV 暴露后预防的个体进行的标准与强化风险降低和依从性咨询的随机非劣效试验。
Clin Infect Dis. 2011 Jul 1;53(1):76-83. doi: 10.1093/cid/cir333.